Hybrigenics Société Anonyme
Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, Fr… Read more
Hybrigenics Société Anonyme (3HB) - Net Assets
Latest net assets as of June 2025: €798.00K EUR
Based on the latest financial reports, Hybrigenics Société Anonyme (3HB) has net assets worth €798.00K EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€5.62 Million) and total liabilities (€4.82 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €798.00K |
| % of Total Assets | 14.19% |
| Annual Growth Rate | -24.26% |
| 5-Year Change | -75.95% |
| 10-Year Change | N/A |
| Growth Volatility | 131.14 |
Hybrigenics Société Anonyme - Net Assets Trend (2016–2024)
This chart illustrates how Hybrigenics Société Anonyme's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Hybrigenics Société Anonyme (2016–2024)
The table below shows the annual net assets of Hybrigenics Société Anonyme from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.18 Million | +163.12% |
| 2023-12-31 | €-1.87 Million | -118.25% |
| 2022-12-31 | €10.23 Million | +8.50% |
| 2021-12-31 | €9.43 Million | +92.36% |
| 2020-12-31 | €4.90 Million | -6.25% |
| 2019-12-31 | €5.23 Million | +308.00% |
| 2018-12-31 | €1.28 Million | -86.01% |
| 2017-12-31 | €9.16 Million | -15.83% |
| 2016-12-31 | €10.88 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Hybrigenics Société Anonyme's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1394000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €19.99 Million | 2526.93% |
| Total Equity | €791.00K | 100.00% |
Hybrigenics Société Anonyme Competitors by Market Cap
The table below lists competitors of Hybrigenics Société Anonyme ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Eros Resources Corp
OTCQB:EROSF
|
$329.39K |
|
MAROC LEASING
BC:MAROC-LEASING
|
$329.42K |
|
2G ENERGY - Dusseldorf Stock Exchang
DU:2GB
|
$329.66K |
|
Fila Korea Ltd.
KQ:081660
|
$329.82K |
|
SHIN-ETSU CHEMICAL - Dusseldorf Stock Exchang
DU:SEH
|
$328.68K |
|
Godolphin Resources Limited
PINK:GDPHF
|
$328.65K |
|
UBEW
BATS:UBEW
|
$328.52K |
|
PAPA JOHNS INTL
MU:PP1
|
$328.02K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hybrigenics Société Anonyme's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -2,097,000 to 791,000, a change of 2,888,000.
- Net loss of 1,101,000 reduced equity.
- Other factors increased equity by 3,989,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-1.10 Million | -139.19% |
| Other Changes | €3.99 Million | +504.3% |
| Total Change | €- | % |
Book Value vs Market Value Analysis
This analysis compares Hybrigenics Société Anonyme's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.98x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.01x to 0.98x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €0.20 | €0.00 | x |
| 2019-12-31 | €0.02 | €0.00 | x |
| 2020-12-31 | €0.02 | €0.00 | x |
| 2021-12-31 | €0.04 | €0.00 | x |
| 2022-12-31 | €0.04 | €0.00 | x |
| 2023-12-31 | €-0.01 | €0.00 | x |
| 2024-12-31 | €0.00 | €0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Hybrigenics Société Anonyme utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -139.19%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -179.32%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 8.16x
- Recent ROE (-139.19%) is below the historical average (-98.78%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -48.65% | -145.78% | 0.22x | 1.50x | €-6.34 Million |
| 2017 | -86.88% | -423.24% | 0.13x | 1.53x | €-8.87 Million |
| 2018 | -587.33% | -9811.40% | 0.02x | 3.12x | €-7.66 Million |
| 2019 | -14.06% | -313.08% | 0.04x | 1.13x | €-1.26 Million |
| 2020 | -6.66% | -216.89% | 0.02x | 1.31x | €-816.99K |
| 2021 | -0.73% | -47.01% | 0.01x | 1.39x | €-1.01 Million |
| 2022 | -5.51% | -36010.86% | 0.00x | 1.49x | €-1.59 Million |
| 2023 | 0.00% | -1285.78% | 0.06x | 0.00x | €-7.66 Million |
| 2024 | -139.19% | -179.32% | 0.10x | 8.16x | €-1.18 Million |
Industry Comparison
This section compares Hybrigenics Société Anonyme's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hybrigenics Société Anonyme (3HB) | €798.00K | -48.65% | 6.05x | $329.27K |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |